Research is at the center of our fight against cancer
LEARN MORE
Developing a new innovative treatment for the most aggressive forms of cancer
LEARN MORE
Our unbounded energy keeps us focused on finding treatments for cancer
LEARN MORE
Cothera Bioscience has acquired zotiraciclib (ZTR) from Adastra and will continue the development. For more information, see link to press release